Cargando…

Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics

BACKGROUND: Vascular risk factors increase the risk of Alzheimer’s disease (AD), but there is limited evidence on whether comorbid vascular conditions and risk factors have an impact on disease progression. The aim of this study was to examine the association between vascular disease and vascular ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldholm, Rannveig Sakshaug, Persson, Karin, Barca, Maria Lage, Knapskog, Anne-Brita, Cavallin, Lena, Engedal, Knut, Selbaek, Geir, Skovlund, Eva, Saltvedt, Ingvild
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964736/
https://www.ncbi.nlm.nih.gov/pubmed/29788900
http://dx.doi.org/10.1186/s12877-018-0813-4
_version_ 1783325237176172544
author Eldholm, Rannveig Sakshaug
Persson, Karin
Barca, Maria Lage
Knapskog, Anne-Brita
Cavallin, Lena
Engedal, Knut
Selbaek, Geir
Skovlund, Eva
Saltvedt, Ingvild
author_facet Eldholm, Rannveig Sakshaug
Persson, Karin
Barca, Maria Lage
Knapskog, Anne-Brita
Cavallin, Lena
Engedal, Knut
Selbaek, Geir
Skovlund, Eva
Saltvedt, Ingvild
author_sort Eldholm, Rannveig Sakshaug
collection PubMed
description BACKGROUND: Vascular risk factors increase the risk of Alzheimer’s disease (AD), but there is limited evidence on whether comorbid vascular conditions and risk factors have an impact on disease progression. The aim of this study was to examine the association between vascular disease and vascular risk factors and progression of AD. METHODS: In a longitudinal observational study in three Norwegian memory clinics, 282 AD patients (mean age 73.3 years, 54% female) were followed for mean 24 (16–37) months. Vascular risk factors and vascular diseases were registered at baseline, and the vascular burden was estimated by the Framingham Stroke Risk Profile (FSRP). Cerebral medical resonance images (MRIs) were assessed for white matter hyperintensities (WMH), lacunar and cortical infarcts. The associations between vascular comorbidity and progression of dementia as measured by annual change in Clinical Dementia Rating Sum of Boxes (CDR-SB) scores were analysed by multiple regression analyses, adjusted for age and sex. RESULTS: Hypertension occurred in 83%, hypercholesterolemia in 53%, diabetes in 9%, 41% were overweight, and 10% were smokers. One third had a history of vascular disease; 16% had heart disease and 15% had experienced a cerebrovascular event. MRI showed lacunar infarcts in 16%, WMH with Fazekas score 2 in 26%, and Fazekas score 3 in 33%. Neither the vascular risk factors and diseases, the FSRP score, nor cerebrovascular disease was associated with disease progression in AD. CONCLUSIONS: Although vascular risk factors and vascular diseases were prevalent, no impact on the progression of AD after 2 years was shown.
format Online
Article
Text
id pubmed-5964736
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59647362018-05-24 Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics Eldholm, Rannveig Sakshaug Persson, Karin Barca, Maria Lage Knapskog, Anne-Brita Cavallin, Lena Engedal, Knut Selbaek, Geir Skovlund, Eva Saltvedt, Ingvild BMC Geriatr Research Article BACKGROUND: Vascular risk factors increase the risk of Alzheimer’s disease (AD), but there is limited evidence on whether comorbid vascular conditions and risk factors have an impact on disease progression. The aim of this study was to examine the association between vascular disease and vascular risk factors and progression of AD. METHODS: In a longitudinal observational study in three Norwegian memory clinics, 282 AD patients (mean age 73.3 years, 54% female) were followed for mean 24 (16–37) months. Vascular risk factors and vascular diseases were registered at baseline, and the vascular burden was estimated by the Framingham Stroke Risk Profile (FSRP). Cerebral medical resonance images (MRIs) were assessed for white matter hyperintensities (WMH), lacunar and cortical infarcts. The associations between vascular comorbidity and progression of dementia as measured by annual change in Clinical Dementia Rating Sum of Boxes (CDR-SB) scores were analysed by multiple regression analyses, adjusted for age and sex. RESULTS: Hypertension occurred in 83%, hypercholesterolemia in 53%, diabetes in 9%, 41% were overweight, and 10% were smokers. One third had a history of vascular disease; 16% had heart disease and 15% had experienced a cerebrovascular event. MRI showed lacunar infarcts in 16%, WMH with Fazekas score 2 in 26%, and Fazekas score 3 in 33%. Neither the vascular risk factors and diseases, the FSRP score, nor cerebrovascular disease was associated with disease progression in AD. CONCLUSIONS: Although vascular risk factors and vascular diseases were prevalent, no impact on the progression of AD after 2 years was shown. BioMed Central 2018-05-22 /pmc/articles/PMC5964736/ /pubmed/29788900 http://dx.doi.org/10.1186/s12877-018-0813-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Eldholm, Rannveig Sakshaug
Persson, Karin
Barca, Maria Lage
Knapskog, Anne-Brita
Cavallin, Lena
Engedal, Knut
Selbaek, Geir
Skovlund, Eva
Saltvedt, Ingvild
Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
title Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
title_full Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
title_fullStr Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
title_full_unstemmed Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
title_short Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
title_sort association between vascular comorbidity and progression of alzheimer’s disease: a two-year observational study in norwegian memory clinics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964736/
https://www.ncbi.nlm.nih.gov/pubmed/29788900
http://dx.doi.org/10.1186/s12877-018-0813-4
work_keys_str_mv AT eldholmrannveigsakshaug associationbetweenvascularcomorbidityandprogressionofalzheimersdiseaseatwoyearobservationalstudyinnorwegianmemoryclinics
AT perssonkarin associationbetweenvascularcomorbidityandprogressionofalzheimersdiseaseatwoyearobservationalstudyinnorwegianmemoryclinics
AT barcamarialage associationbetweenvascularcomorbidityandprogressionofalzheimersdiseaseatwoyearobservationalstudyinnorwegianmemoryclinics
AT knapskogannebrita associationbetweenvascularcomorbidityandprogressionofalzheimersdiseaseatwoyearobservationalstudyinnorwegianmemoryclinics
AT cavallinlena associationbetweenvascularcomorbidityandprogressionofalzheimersdiseaseatwoyearobservationalstudyinnorwegianmemoryclinics
AT engedalknut associationbetweenvascularcomorbidityandprogressionofalzheimersdiseaseatwoyearobservationalstudyinnorwegianmemoryclinics
AT selbaekgeir associationbetweenvascularcomorbidityandprogressionofalzheimersdiseaseatwoyearobservationalstudyinnorwegianmemoryclinics
AT skovlundeva associationbetweenvascularcomorbidityandprogressionofalzheimersdiseaseatwoyearobservationalstudyinnorwegianmemoryclinics
AT saltvedtingvild associationbetweenvascularcomorbidityandprogressionofalzheimersdiseaseatwoyearobservationalstudyinnorwegianmemoryclinics